DANTAS, L. M.; http://lattes.cnpq.br/7959623464605749; DANTAS, Lívia Mendes.
Abstract:
The epidemic of AIDS infection is present globally. In Brazil, in 2015,
more than 700,000 new cases of AIDS were registered. Despite the studies to
regarding etiopathogenesis, pathophysiology and transmission mechanisms, the
prevalence and incidence are still high. With the advent of drugs
antiretroviral drugs, the prognosis and quality of life of patients with HIV
were significantly improved and morbidity and mortality from the virus and its
complications have decreased dramatically. However, the incidence of some
non-AIDS-related illnesses, cardiovascular disease and diabetes
mellitus, shows a growing trend, and these have become one of the main
causes of morbidity in patients with HIV. The aim of the present study was
describe the profile of people living with HIV/AIDS and diabetes mellitus
treated at the University Hospital Alcides Carneiro during the period from April to
August 2017. The population is 56.9% male, with an average age of
47.82 years old, mixed race, single, primary education level, eminently
busy. From the behavioral point of view, only three (4.2%) have the practice of
routine physical activity. A minority is also a smoker, drinker or uses
illicit drugs. From the clinical-laboratory point of view, the patients present an average
time since diagnosis of HIV infection of 8.98 years; 72.2% are under the use of
antiretroviral drugs for more than three years and 43% of them under regimen
containing protease inhibitors. Patients have good virological control and
immune system, 72% with suppressed viral load and almost 90% with
CD4+ T lymphocytes above 200 cels̸mm3. Only three (4.2%) patients were
identified as having diabetes mellitus and one (1.4%) with intolerance to
glucose in the studied population. However, the high frequency of medical records in
whose data regarding the glycemic profile were absent did not allow us to infer
plausible conclusions. Larger studies with the current population, in particular
prospective studies, should be performed so that a better glycemic profile can be
traced. From now on, this work contributes with the suggestion of establishing a
screening routine and recording of specific items related to the glycemic profile having
with a view to reducing possible morbidities associated with antiretroviral therapy.